260 related articles for article (PubMed ID: 31432188)
1. The identification of CRNDE, H19, UCA1 and HOTAIR as the key lncRNAs involved in oxaliplatin or irinotecan resistance in the chemotherapy of colorectal cancer based on integrative bioinformatics analysis.
Sun F; Liang W; Qian J
Mol Med Rep; 2019 Oct; 20(4):3583-3596. PubMed ID: 31432188
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer.
Lampropoulou DI; Aravantinos G; Katifelis H; Lazaris F; Laschos K; Theodosopoulos T; Papadimitriou C; Gazouli M
Cancer Biomark; 2019; 25(2):213-221. PubMed ID: 31045514
[TBL] [Abstract][Full Text] [Related]
3. Identification of long noncoding RNA expression profile in oxaliplatin-resistant hepatocellular carcinoma cells.
Yin X; Zheng SS; Zhang L; Xie XY; Wang Y; Zhang BH; Wu W; Qiu S; Ren ZG
Gene; 2017 Jan; 596():53-88. PubMed ID: 27729273
[TBL] [Abstract][Full Text] [Related]
4. Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecan.
Poorebrahim M; Sadeghi S; Ghanbarian M; Kalhor H; Mehrtash A; Teimoori-Toolabi L
Cancer Chemother Pharmacol; 2020 Jan; 85(1):153-171. PubMed ID: 31781855
[TBL] [Abstract][Full Text] [Related]
5. Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.
Makondi PT; Chu CM; Wei PL; Chang YJ
PLoS One; 2017; 12(7):e0180616. PubMed ID: 28749961
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin and irinotecan induce heterogenous changes in the EMT markers of metastasizing colorectal carcinoma cells.
Skarkova V; Kralova V; Krbal L; Matouskova P; Soukup J; Rudolf E
Exp Cell Res; 2018 Aug; 369(2):295-303. PubMed ID: 29842879
[TBL] [Abstract][Full Text] [Related]
7. Identification and prediction of novel non-coding and coding RNA-associated competing endogenous RNA networks in colorectal cancer.
Liang Y; Zhang C; Ma MH; Dai DQ
World J Gastroenterol; 2018 Dec; 24(46):5259-5270. PubMed ID: 30581274
[TBL] [Abstract][Full Text] [Related]
8. Toward Colorectal Cancer Biomarkers: The Role of Genetic Variation, Wnt Pathway, and Long Noncoding RNAs.
Abdel-Motaleb AI; Azzazy HM; Moustafa A
OMICS; 2021 May; 25(5):302-312. PubMed ID: 33891491
[TBL] [Abstract][Full Text] [Related]
9. MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis.
Li L; Shang J; Zhang Y; Liu S; Peng Y; Zhou Z; Pan H; Wang X; Chen L; Zhao Q
Oncol Rep; 2017 Sep; 38(3):1383-1392. PubMed ID: 28731151
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNAs: Key regulators in oxaliplatin resistance of colorectal cancer.
Qi FF; Yang Y; Zhang H; Chen H
Biomed Pharmacother; 2020 Aug; 128():110329. PubMed ID: 32502843
[TBL] [Abstract][Full Text] [Related]
11. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cells.
Deng X; Ruan H; Zhang X; Xu X; Zhu Y; Peng H; Zhang X; Kong F; Guan M
Int J Cancer; 2020 Mar; 146(6):1700-1716. PubMed ID: 31381140
[TBL] [Abstract][Full Text] [Related]
13. Microarray Analysis of Long Non-coding RNA Expression Profile Associated with 5-Fluorouracil-Based Chemoradiation Resistance in Colorectal Cancer Cells.
Xiong W; Jiang YX; Ai YQ; Liu S; Wu XR; Cui JG; Qin JY; Liu Y; Xia YX; Ju YH; He WJ; Wang Y; Li YF; Hou Y; Wang L; Li WH
Asian Pac J Cancer Prev; 2015; 16(8):3395-402. PubMed ID: 25921151
[TBL] [Abstract][Full Text] [Related]
14. LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan.
Fakhr E; Zare F; Azadmanesh K; Teimoori-Toolabi L
Biomed Pharmacother; 2021 Nov; 143():112091. PubMed ID: 34474344
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis.
Wang H; Li H; Zhang L; Yang D
Biomed Pharmacother; 2018 Oct; 106():1607-1615. PubMed ID: 30119236
[TBL] [Abstract][Full Text] [Related]
16. Temporal expression and functional analysis of long non-coding RNAs in colorectal cancer initiation.
Dai L; Li J; Dong Z; Liu Y; Chen Y; Chen N; Cheng L; Fang C; Wang H; Ji Y; Chen S; Su X; Shi G; Lin Y; Zhang S; Yang Y; Qiu M; Yu D; Huang W; Zhou Z; Wei Y; Deng H
J Cell Mol Med; 2019 Jun; 23(6):4127-4138. PubMed ID: 30920116
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy.
Wang M; Han D; Yuan Z; Hu H; Zhao Z; Yang R; Jin Y; Zou C; Chen Y; Wang G; Gao X; Wang X
Cell Death Dis; 2018 Nov; 9(12):1149. PubMed ID: 30451820
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of long non-coding RNA competing interactions reveals the potential role in progression of human gastric cancer.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Int J Oncol; 2016 May; 48(5):1965-76. PubMed ID: 26935047
[TBL] [Abstract][Full Text] [Related]
19. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA ARSR is associated with a poor prognosis in patients with colorectal cancer.
Li T; Jin X; Dong J; Deng H
J Gene Med; 2020 Oct; 22(10):e3241. PubMed ID: 32558022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]